top
Search terms
Results 11 - 13 of 13 - ordered by :
Pages: 1 2
Ehjournal

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial ...

European Heart Journal, Landmesser, Ulf, Chapman, M John, Stock, Jane K, Amarenco, Pierre, Belch, Jill J F, Borén, Jan, Farnier, Michel, Ference, Brian A, Gielen, Stephan, Graham, Ian, Grobbee, ...

Date : 07/04/2018 Item size : 536298 bytes
Ehjournal

Rare genetic mutations that cause reduced LDL receptor function lead to markedly higher LDL-C and a dose-dependent increase in the risk of ASCVD, whereas rare variants leading to lower LDL-C are ...

European Heart Journal, Ference, Brian A., Ginsberg, Henry N., Graham, Ian, Ray, Kausik K., Packard, Chris J., Bruckert, Eric, Hegele, Robert A., Krauss, Ronald M., Raal, Frederick J., Schunkert, ...

Date : 21/08/2017 Item size : 594859 bytes
Ehjournal

The causality of plasma low-density lipoprotein-cholesterol (LDL-C) and reduced LDL receptor-mediated LDL uptake in the pathophysiology of ASCVD has been established beyond any reasonable doubt.3 For ...

European Heart Journal, Landmesser, Ulf, John Chapman, M., Farnier, Michel, Gencer, Baris, Gielen, Stephan, Hovingh, G. Kees, Lüscher, Thomas F., Sinning, David, Tokgözoğlu, Lale, Wiklund, ...

Date : 01/08/2017 Item size : 477757 bytes